SCHEMBL25541010

SCHEMBL25541010

CCCC(C)(C)c1cccc2cnccc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SSTR4 P31391 2/20 0.46
LMNA P02545 4/20 0.46
CYP3A4 P08684 4/20 0.46
CYP2D6 P10635 3/20 0.46
KDM4E B2RXH2 3/20 0.46
CYP1A2 P05177 2/20 0.46
CYP2C19 P33261 2/20 0.46
CYP2C9 P11712 1/20 0.46
MAPKAPK2 P49137 1/20 0.46
HTT P42858 2/20 0.42
ROCK2 O75116 2/20 0.42
ROCK1 Q13464 2/20 0.42
ALDH1A1 P00352 2/20 0.42
PRKD3 O94806 3/20 0.42
PRKCG P05129 3/20 0.42
PRKCB P05771 3/20 0.42
PRKCA P17252 3/20 0.42
PRKCH P24723 3/20 0.42
PRKCI P41743 3/20 0.42
PRKCE Q02156 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22794684 0.91 LMNA (0.46) SSTR4LMNACYP3A4CYP2D6KDM4E
SCHEMBL25529096 0.87 LMNA (0.49) SSTR4LMNACYP3A4CYP2D6KDM4E
SCHEMBL21165459 0.82 SSTR4 (0.43) SSTR4CYP3A4CYP2D6KDM4ECYP1A2
SCHEMBL19256234 0.81 IMPDH2 (0.36) SSTR4LMNACYP3A4CYP2D6KDM4E
SCHEMBL1691498 0.81 LMNA (0.53) SSTR4LMNACYP3A4CYP2D6KDM4E
SCHEMBL19257091 0.80 IMPDH2 (0.47) LMNACYP3A4CYP2D6KDM4ECYP1A2
SCHEMBL2126064 0.79 CYP2A6 (0.40) LMNACYP2D6KDM4ECYP1A2CYP2C19
SCHEMBL25857904 0.79 EGFR (0.41) SSTR4LMNACYP3A4CYP2D6KDM4E
SCHEMBL16110169 0.78 KDM4E (0.55) SSTR4LMNACYP3A4CYP2D6KDM4E
SCHEMBL16240697 0.78 LMNA (0.55) SSTR4LMNACYP3A4CYP2D6KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230242531-A1 Monoacylglycerol Lipase Modulators JANSSEN PHARMACEUTICA NV (BE) 2023-08-03 US disclosed
US-20230145249-A1 Monoacylglycerol Lipase Modulators JANSSEN PHARMACEUTICA NV (BE) 2023-05-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230242531-A1 Monoacylglycerol Lipase Modulators MGLL, LPL, PNLIP SSTR4 2812/4885LMNA 1845/4885CYP3A4 1831/4885
US-20230145249-A1 Monoacylglycerol Lipase Modulators MGLL, LPL, PNLIP SSTR4 2673/4885LMNA 1308/4885CYP3A4 1414/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.